Standardised method of determining vibratory perception thresholds for diagnosis and screening in neurological investigation.

Goldberg, Jay M.; Lindblom, Ulf

doi:10.1136/jnnp.42.9.793

Cited by 378 publications

(199 citation statements)

References 27 publications

Supporting

Mentioning

173

Contrasting

Unclassified

Order By: Relevance

“…It is not unusual for the descending vibration perception reading to be lower than the ascending readings. The VPT recorded for the descending test is generally less distinct and the participant may occasionally find it difficult to determine when the vibration sensation has in fact disappeared [37]. Pacinian corpuscles have been identified as the receptors responsible for the transduction of vibratory energy [38], with increasing pressure of the vibrating stimuli resulting in an increase of the frequency discharge from Pacinian corpuscles [38].…”

Section: Discussionmentioning

confidence: 99%

“…VPT measurements were consistently higher for the right limbs and this might reflect the fact that the study protocol initiated the vibration measures on the right foot and right hand, respectively. Previously published literature documents the effect of age [10,37] and height [10,28] on VPT measurements. For men and women we found statistically significant linear associations between the distal leg and distal arm VPT measurements (average of six readings across limbs) and age, with VPT increasing with age.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Vibrotactile threshold measurement for detecting peripheral neuropathy: defining variability and a normal range for clinical and research use

et al. 2007

View full text Add to dashboard Cite

Aims/hypothesis We aimed to define normal ranges for vibration sense as measured by vibratory perception thresholds (VPTs) using biothesiometry. Methods We performed biothesiometry in a communitydwelling sample of 901 people aged 55 to 85 years who did not have diabetes. We quantitated the variation between repeat measures using analysis of variance and BlandAltman plots. We also plotted the age-and sex-specific reference ranges. Results We found small but statistically significant differences between repeat measures using the ascending and descending method of limits. Statistically higher vibration thresholds were noted on the right arm and leg compared with the left. Significantly higher vibration thresholds were also seen in men vs women for both lower limbs. We also defined sex-specific reference intervals (normal ranges) for biothesiometry for older persons and quantitated the increase in vibration threshold with increasing age. Conclusions/interpretation For reliability, it may be sufficient to obtain the average of two ascending measures separated by at least 1 min in just the right hand or right foot, since this is usually the one with the higher threshold. Although identical reference ranges can be used for men and women for the upper limb, there are significant differences in the lower limbs. The major determinant of VPT is age: we have established age-specific norms for VPT testing for adults between 55 and 85 years of age.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Vibrotactile threshold measurement for detecting peripheral neuropathy: defining variability and a normal range for clinical and research use

et al. 2007

View full text Add to dashboard Cite

show abstract

“…These are semi-quantitative, reliable measurements, complementary to each other, with proven predictive value for the development of clinical problems, such as foot ulcers and the need for amputation (Goldberg and Lindblom, 1979;Bloom et al, 1984;Birke and Sims, 1986;Sosenko et al, 1990;Kumar et al, 1991;Veves et al, 1994;Young et al, 1994;Valk et al, 1997). Both were applied 6 times to two locations on both feet.…”

Section: La Neuropathymentioning

confidence: 99%

Evaluation of a screening and prevention programme for diabetic foot complications

Meijer

Links²,

Smit

et al. 2001

Prosthetics &Amp; Orthotics International

View full text Add to dashboard Cite

Foot complications in diabetes can be decreased by preventive measures. The authors evaluated the current diabetic foot screening and prevention programme of the diabetes outpatient clinic of their university hospital, by assessing the presence of risk factors for the development of foot disorders and the preventive measures taken.Fifty (50) diabetic patients not known to have foot complications were selected at random. Risk factors and preventive measures were inventarised with the Coleman riskcategorization system and the Preventive Measures Scale, respectively.Sixty per cent (60%) of the patients were at risk of developing diabetic foot complications. The preventive measures were low in these patients. Patient knowledge was insufficient and behaviour even worse. Basal preventive shoe adaptations were absent in most patients at risk. No relation between risk category and the preventional status was found.Cross-sectional examination at a university outpatient clinic showed serious risk profiles for foot complications, which were not balanced by the application of generally accepted preventive measures. At the outpatient clinic, screening should be optimised.

show abstract

“…Neurological evaluation was carried out as described previously (Goldberg and Lindblom, 1979; Gerritsen Van Der Hoop et al, 1990) before entry in the study, at 2 weeks and at 3 and 6 months after the end of the cisplatin therapy. Briefly, the severity of neuropathy was evaluated by a questionnaire of neurological symptoms, by performing a sensory neurological examination and by measurement of the vibration perception threshold (VPT).…”

mentioning

confidence: 99%

Relationship between the exposure to cisplatin, DNA-adduct formation in leucocytes and tumour response in patients with solid tumours

Schellens¹,

Ma²,

Planting³

et al. 1996

Br J Cancer

120

View full text Add to dashboard Cite

Standardised method of determining vibratory perception thresholds for diagnosis and screening in neurological investigation.

Cited by 378 publications

References 27 publications

Vibrotactile threshold measurement for detecting peripheral neuropathy: defining variability and a normal range for clinical and research use

Vibrotactile threshold measurement for detecting peripheral neuropathy: defining variability and a normal range for clinical and research use

Evaluation of a screening and prevention programme for diabetic foot complications

Relationship between the exposure to cisplatin, DNA-adduct formation in leucocytes and tumour response in patients with solid tumours

Contact Info

Product

Resources

About